Diagnostics (Jan 2020)

Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence & Aggressiveness

  • Edward J. Pavlik,
  • Christopher Smith,
  • Taylor S. Dennis,
  • Elizabeth Harvey,
  • Bin Huang,
  • Quan Chen,
  • Dava West Piecoro,
  • Brian T. Burgess,
  • Anthony McDowell,
  • Justin Gorski,
  • Lauren A. Baldwin,
  • Rachel W. Miller,
  • Christopher P. DeSimone,
  • Charles Dietrich,
  • Holly H. Gallion,
  • Frederick R. Ueland,
  • John R. van Nagell

DOI
https://doi.org/10.3390/diagnostics10020056
Journal volume & issue
Vol. 10, no. 2
p. 56

Abstract

Read online

Epithelial ovarian cancers (EOC) consist of several sub-types based on histology, clinical, molecular and epidemiological features that are termed “histo-types”, which can be categorized into less aggressive Type I and more aggressive Type II malignancies. This investigation evaluated the disease-specific survival (DSS) of women with Type I and II EOC using histo-type, grade, and stage. A total of 47,789 EOC cases were identified in the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) data. Survival analysis and log rank test were performed to identify a 2-tiered classification (grade 1 vs. grade 2 & 3) for serous EOC. DSS of early stage serous EOC for grade 2 was significantly different from grade 3 indicating that a 2-tier classification for serous EOC applied only to late stage. DSS of Type I EOC was much better than Type II. However, DSS was 33−52% lower with late stage Type I than with early stage Type I indicating that Type I ovarian cancers should not be considered indolent. Early stage Type II EOC had much better DSS than late stage Type II stressing that stage has a large role in survival of both Type I and II EOC.

Keywords